Coherus, Junshi Biosciences Say FDA Accepts Resubmission Of Toripalimab BLA

RTTNews | 1211 dni temu
Coherus, Junshi Biosciences Say FDA Accepts Resubmission Of Toripalimab BLA

(RTTNews) - Coherus BioSciences, Inc. (CHRS) and Shanghai Junshi Biosciences Co., Ltd. announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) resubmission for toripalimab in combination with gemcitabine and cisplatin as first-line treatment for patients with advanced recurrent or metastatic nasopharyngeal carcinoma (NPC) and for toripalimab monotherapy for the second-line or later treatment of recurrent or metastatic NPC after platinum-containing chemotherapy.

The FDA has set a Prescription Drug User Fee Act (PDUFA) action date for December 23, 2022. The Agency earlier communicated that the review timeline for the BLA resubmission would be six months, as onsite inspections in China would be required.

The travel restrictions related to the COVID-19 pandemic previously hindered the FDA's ability to complete required inspections. Coherus plans to launch toripalimab in the U.S. in the first quarter of 2023, if approved.

For More Such Health News, visit rttnews.com.

read more
Coherus Rolls Out YUSIMRY At $995 Per Carton In US

Coherus Rolls Out YUSIMRY At $995 Per Carton In US

Coherus BioSciences, Inc. (CHRS) announced Monday that YUSIMRY (adalimumab-aqvh) is now available for commercial sale in the United States at a list price of $995 per carton for two 40 mg/0.8 mL autoinjectors.
RTTNews | 849 dni temu
Malaysia Stock Market May Spin Its Wheels On Thursday

Malaysia Stock Market May Spin Its Wheels On Thursday

The Malaysia stock market has finished lower in back-to-back sessions, slipping almost 7 points or 0.4 percent in that span. The Kuala Lumpur Composite Index now sits just above the 1,610-point plateau and it may remain stuck in neutral on Thursday.
RTTNews | 10 minut temu
Japan Bourse May See Mild Downside Correction

Japan Bourse May See Mild Downside Correction

The Japan stock market rebounded on Wednesday, one day after ending the two-day winning streak in which it had rallied more than 1,800 points or 3 percent. The Nikkei 225 now rests just above the 51,300-point plateau although it may run out of steam on Thursday.
RTTNews | 25 minut temu
South Korea Shares May Be Stuck In Neutral

South Korea Shares May Be Stuck In Neutral

The South Korea stock market bounced higher again on Wednesday, one day after halting the two-day winning streak in which it had gained almost 200 points or 5 percent. Now at a fresh record closing high, the KOSPI sits just above the 4,080-point plateau although investors may lock in gains on Thursday.
RTTNews | 40 minut temu
Japan Rate Decision On Tap For Thursday

Japan Rate Decision On Tap For Thursday

The Bank of Japan will wrap up its monetary policy meeting on Thursday and then announce its decision on interest rates, highlighting a modest day for Asia-Pacific economic activity. The BoJ is expected to keep its benchmark lending rate steady at 0.50 percent.
RTTNews | 1g 40 minut temu
Swiss Market Ends On Weak Note

Swiss Market Ends On Weak Note

After spending a few minutes in positive territory at the start, Switzerland stock market's benchmark SMI drifted down and then stayed weak right through the trading session on Wednesday, with investors digesting corporate earnings updates and looking ahead to the Federal Reserve's rate decision due later in the day.
RTTNews | 4g 58 minut temu
Fed Announces Widely Expected Decision To Cut Rates By Another Quarter Point

Fed Announces Widely Expected Decision To Cut Rates By Another Quarter Point

After cutting interest rates for the first time this year in September, the Federal Reserve on Wednesday announced its widely expected decision to lower rates by another quarter point. The Fed said it decided to lower the target range for the federal funds rate by 25 basis points to 3.75 percent to 4.0 percent in support of its dual goals.
RTTNews | 5g 25 minut temu
Major European Markets Close On Mixed Note Ahead Of Fed Rate Decision

Major European Markets Close On Mixed Note Ahead Of Fed Rate Decision

European stocks turned in a mixed performance on Wednesday with investors reacting to a slew of earnings announcements, and looking ahead to the monetary policy announcement from the Federal Reserve later in the day, and the upcoming meeting between U.S. President Donald Trump and his Chinese counterpart Xi Jinping. Investors also looked ahead to the ECB's policy announcement due tomorrow.
RTTNews | 5g 27 minut temu